Skip to main content

Scynexis Inc

SCYX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001178253

No open-market purchases or sales by Scynexis Inc insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Scynexis Inc changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of SCYX: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders4840−8
Shares12.1M11.6M−477.3K (−3.9%)
Value$14.6M$11.0M−$3.57M (−24.4%)

New holders (4)

Institutions that held Scynexis Inc at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to SCYX in Q1 2025
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP30,420$29.0K0.00%
Raymond James Financial Inc21,584$20.6K0.00%
Pingora Partners LLC12,000$11.4K0.01%
Royal Bank of Canada1,000$1.00K0.00%

Sold out (12)

Institutions that held Scynexis Inc at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of SCYX in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
UBS Oconnor LLC195,393$236.4K
Engineers Gate Manager LP42,234$51.1K
Jane Street Group, LLC26,507$32.1K
Millennium Management LLC25,887$31.3K
Two Sigma Securities, LLC20,560$24.9K
National Bank of Canada20,000$24.2K
Bleakley Financial Group, LLC20,000$24.2K
Tower Research Capital LLC (TRC)3,560$4.31K
FMR LLC2,200$2.66K
MAI Capital Management500$605
Richards, Merrill & Peterson, Inc.110$133
Simplex Trading, LLC350$0